Cite
HARVARD Citation
Alexander, T. et al. (2014). A3.26 Proteasome inhibition with bortezomib in refractory SLE inhibits type I interferon and depletes plasma cells but does not inhibit their regeneration. Annals of the rheumatic diseases. p. A52. [Online].